7
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Age-related decline in circulating IGF-1 associates with impaired neurovascular coupling responses in older adults

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Impairment of moment-to-moment adjustment of cerebral blood flow (CBF) to the increased oxygen and energy requirements of active brain regions via neurovascular coupling (NVC) contributes to the genesis of age-related cognitive impairment. Aging is associated with marked deficiency in the vasoprotective hormone insulin-like growth factor-1 (IGF-1). Preclinical studies on animal models of aging suggest that circulating IGF-1 deficiency is causally linked to impairment of NVC responses. The present study was designed to test the hypotheses that decreases in circulating IGF-1 levels in older adults also predict the magnitude of age-related decline of NVC responses. In a single-center cross-sectional study, we enrolled healthy young ( n = 31, 11 female, 20 male, mean age: 28.4 + / − 4.2 years) and aged volunteers ( n = 32, 18 female, 14 male, mean age: 67.9 + / − 4.1 years). Serum IGF-1 level, basal CBF (phase contrast magnetic resonance imaging (MRI)), and NVC responses during the trail making task (with transcranial Doppler sonography) were assessed. We found that circulating IGF-1 levels were significantly decreased with age and associated with decreased basal CBF. Age-related decline in IGF-1 levels predicted the magnitude of age-related decline in NVC responses. In conclusion, our study provides additional evidence in support of the concept that age-related circulating IGF-1 deficiency contributes to neurovascular aging, impairing CBF and functional hyperemia in older adults.

          Related collections

          Most cited references82

          • Record: found
          • Abstract: found
          • Article: not found

          Glial and neuronal control of brain blood flow.

          Blood flow in the brain is regulated by neurons and astrocytes. Knowledge of how these cells control blood flow is crucial for understanding how neural computation is powered, for interpreting functional imaging scans of brains, and for developing treatments for neurological disorders. It is now recognized that neurotransmitter-mediated signalling has a key role in regulating cerebral blood flow, that much of this control is mediated by astrocytes, that oxygen modulates blood flow regulation, and that blood flow may be controlled by capillaries as well as by arterioles. These conceptual shifts in our understanding of cerebral blood flow control have important implications for the development of new therapeutic approaches.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            The many faces of insulin-like peptide signalling in the brain.

            Central and peripheral insulin-like peptides (ILPs), which include insulin, insulin-like growth factor 1 (IGF1) and IGF2, exert many effects in the brain. Through their actions on brain growth and differentiation, ILPs contribute to building circuitries that subserve metabolic and behavioural adaptation to internal and external cues of energy availability. In the adult brain each ILP has distinct effects, but together their actions ultimately regulate energy homeostasis - they affect nutrient sensing and regulate neuronal plasticity to modulate adaptive behaviours involved in food seeking, including high-level cognitive operations such as spatial memory. In essence, the multifaceted activity of ILPs in the brain may be viewed as a system organization involved in the control of energy allocation.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Administration and interpretation of the Trail Making Test.

              Measurement of cognitive functions is an increasingly important goal for clinicians and researchers. Many neuropsychological test batteries are comprehensive and require specialized training to administer and interpret. The Trail Making Test is an accessible neuropsychological instrument that provides the examiner with information on a wide range of cognitive skills and can be completed in 5-10 min. Its background, psychometric properties, administration procedures and interpretive guidelines are provided in this protocol.
                Bookmark

                Author and article information

                Contributors
                toth.peter@pte.hu
                Journal
                GeroScience
                Geroscience
                GeroScience
                Springer International Publishing (Cham )
                2509-2715
                2509-2723
                23 July 2022
                23 July 2022
                December 2022
                : 44
                : 6
                : 2771-2783
                Affiliations
                [1 ]GRID grid.9679.1, ISNI 0000 0001 0663 9479, Department of Neurosurgery, Medical School, , University of Pecs, ; 2 Ret Street, Pecs, 7624 Hungary
                [2 ]GRID grid.9679.1, ISNI 0000 0001 0663 9479, Institute for Translational Medicine, Medical School, , University of Pecs, ; Pecs, Hungary
                [3 ]GRID grid.266902.9, ISNI 0000 0001 2179 3618, Vascular Cognitive Impairment and Neurodegeneration Program, Oklahoma Center for Geroscience and Healthy Brain Aging, Department of Biochemistry and Molecular Biology, , University of Oklahoma Health Sciences Center, ; Oklahoma City, OK USA
                [4 ]ELKH-PTE Clinical Neuroscience MR Research Group, Eötvös Lóránd Research Network (ELKH), Pecs, Hungary
                [5 ]GRID grid.9679.1, ISNI 0000 0001 0663 9479, Department of Neurology, Medical School, , University of Pecs, ; Pecs, Hungary
                [6 ]GRID grid.266902.9, ISNI 0000 0001 2179 3618, Department of Health Promotion Sciences, College of Public Health, , University of Oklahoma Health Sciences Center, ; Oklahoma City, OK USA
                [7 ]GRID grid.266902.9, ISNI 0000 0001 2179 3618, The Peggy and Charles Stephenson Cancer Center, , University of Oklahoma Health Sciences Center, ; Oklahoma City, OK 73104 USA
                [8 ]GRID grid.11804.3c, ISNI 0000 0001 0942 9821, International Training Program in Geroscience, Doctoral School of Basic and Translational Medicine/Department of Public Health, , Semmelweis University, ; Budapest, Hungary
                Author information
                http://orcid.org/0000-0003-1077-9348
                Article
                623
                10.1007/s11357-022-00623-2
                9768079
                35869380
                603391eb-cc48-447c-8daa-68c9513fb3b7
                © The Author(s) 2022

                Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

                History
                : 24 April 2022
                : 9 July 2022
                Funding
                Funded by: FundRef http://dx.doi.org/10.13039/501100012550, Nemzeti Kutatási, Fejlesztési és Innovaciós Alap;
                Award ID: NKFI-FK123798
                Award ID: NKFI-K 134555
                Award ID: TKP2021-EGA-16
                Award ID: TKP2021-NKTA-47
                Award ID: TKP2021-NVA
                Funded by: FundRef http://dx.doi.org/10.13039/501100003825, Magyar Tudományos Akadémia;
                Funded by: FundRef http://dx.doi.org/10.13039/100000049, National Institute on Aging;
                Award ID: RF1AG072295
                Award ID: R01AG055395
                Award ID: R01AG068295; K01-AG073614
                Funded by: FundRef http://dx.doi.org/10.13039/100000065, National Institute of Neurological Disorders and Stroke;
                Award ID: R01NS100782
                Funded by: FundRef http://dx.doi.org/10.13039/100008746, National Cancer Center;
                Award ID: R01CA255840
                Funded by: Cellular and Molecular GeroScience
                Award ID: P20GM125528
                Funded by: University of Pécs
                Categories
                Article
                Custom metadata
                © The Author(s), under exclusive licence to American Aging Association 2022

                neurovascular uncoupling,cognitive decline,vascular cognitive impairment,vci,vcid,aging

                Comments

                Comment on this article